Anthracyclines, Adriamycin, Rat Heart M itochondria, Rat Liver Mitochondria, Oxygen Radicals
Introduction
In the USA the majority of tum or patients is treated with anticancer drugs of the anthracycline family. The development of dose-dependent car diomyopathy is the main limitation in the treat ment with anthracyclines (adriamycin, AQ) (C ar ter, 1975) . Although much literature exists on this problem it is still unclear why the heart is particu larly susceptible to AQ. There is general agreement that heart mitochondria are the major toxicological target for AQ (Sokolove, 1994) . This becomes apparent by the morphological alter ations which occur in hearts subjected to AQ treatment. Considering that heart mitochondria which account for 40% of the total mass of the cardiac muscle supply the organ with energy in the form of ATP for physiological and biochemical activities, it is clear that any harm to these vital organelles has severe consequences for the func tion of the heart. Thus, most research efforts made to clarify the pathogenesis of cardiomyopathy were focused on the response of cardiac mito chondria to AQ. Table I lists some pertinent mitochondrial alter ations collected from the literature, each of which being suggested to be the key event in AQ-induced cardiomyopathy (Carter, 1975; Sokolove et al., 1993; Youngman et al., 1984; Monti et al., 1986; M atsumura et al., 1994; Demant, 1991; Iwamoto et al., 1974; Ji and Mitchell, 1994) . Although all of these alterations reported may have severe consequences on heart function, evidences are lacking which exclude that these events could oc cur with mitochondria of other tissues as well. Most of the proposed mechanisms can be directly or indirectly related to the establishment of oxida-0939-5075/98/0300-0279 $ 06.00 © 1998 Verlag der Zeitschrift für Naturforschung. All rights reserved. tive stress, which is generally accepted to play a role.
It is also generally accepted that oxidative stress is developed via one-electron redox cycling of AQ and that N AD H must be added to the mito chondrial suspension to start this toxicogenetic metabolism (Davies and Doroshow, 1986a; Nohl and Jordan, 1983; Nohl, 1988) .
Progress in the understanding of the cardioselective toxicology of AQ was made by a report on a heart-specific mitochondrial enzyme which cata lyzes the oxidation of cytosolic N AD H (Fig. 1 ) (Nohl, 1987) . The enzyme introduces reducing equivalents from cytosolic NADH into complex I exhibiting a strong negative redox potential. The redox potential is about -360 mV, which is negative enough to reduce most anticancer drugs of the AQ family to the semiquinone form (AQ) (Nohl, 1988) .
Results and Discussion
O ur experim ents revealed that A Q ' were formed by rat heart mitochondria (RHM ) when external N A D H was present (A Q " g=2.0039, ZlHpp = 3.75 G, isotropic, at 200 K and 5mW microwave power), while succinate was ineffective (ESR signal intensity was about 20 times lower).
During control experiments carried out in the ab sence of AQ no significant ESR signal intensity was observed excluding the contribution of ubisemiquinones to the signal observed in presence of AQ. AQ seems to directly interact at the oxi dant site of the exogenous N AD H dehydrogenase. Evidence for this assumption comes from the use of rotenone, an inhibitor which blocks out input of reducing equivalents from N AD H into the re spiratory chain. In contrast rotenone-inhibited mitochondria were even more active in generating AQ-in the presence of NADH. Since rotenone excludes any other com ponent of the respiratory chain from the transfer of reducing equivalents it was assumed that AQ can serve as one-electron acceptor at the oxidant site of the exogenous NAD H dehydrogenase. Rat liver mitochondria (RLM ) suspensions mildly catalyzed one-electron reduction of AQ both with succinate and N AD H (about 4 times less than N A D H-supplem ented RHM ) due to the adherence of a small portion of damaged mitochondria (<5%). This, however, can be excluded to occur with intact RLM since liver mitochondria do not have an exogenous N AD H dehydrogenase (Nohl, 1987) , and due to the high polarity NADH and AQ compounds do not have access to the respective catalysts of intact m ito chondria. The am ount of AQ -obtained in RHM was dependent on the presence or absence of oxy gen illustrating the involvement of 0 2 in redox cy- cling of AQ. Oxygen serves as an one-electron ac ceptor of AQ -and forms 0 2~ ' radicals.
The rate of 0 2~ ■ formation evolving from this cycle is hard to follow by classical detection m eth ods. Adrenochrom e absorbs light in the range of anthracyclines, cytochrome c is not able to penet rate into the intram em brane space of mito chondria where 0 2~' release was expected to oc cur. A more reliable method is the determ ination of 0 2 consumption in mitochondria in which elec tron flow to cytochrome oxidase was inhibited with rotenone and in addition cytochrome oxidase was knocked out as the major mitochondrial 0 2 sink by CN~ ligand binding (Fig. 2) . U nder these conditions autoxidation of AQ • is the only way by which oxygen is consumed. With this system it was possible to follow indirectly 0 2~ • formation from autoxidizing AQ-with increasing AQ concentra tions. K m and Vmax values were calculated from the double reciprocal plot of Fig. 2 . Based on Vmax values one can estimate that 3 -5 % of the total mitochondrial oxygen consumption runs into 0 2~ • form ation via autoxidizing AQ \ The K m value was 1 0 times above the one reported for submitochondrial particles (SMP) of RHM (Doroshow and D a vies, 1986) which stresses the involvement of the exogenous NAD H dehydrogenase in AQ redoxcycling. Tissue concentrations established during AQ treatm ent are considerably below K m values (15 times). This means that the toxicity of the drug increases exponentially when approaching the K m level (Sokolove et al., 1993) .
Using 5 a mixed ESR spectrum of overlapping DM PO-O O H (an = 14.1 G, aH = 11.3 G) and DM PO-OH (an = 14.9 G, aH -14.9 G) adducts (Fig. 3A) . The presence of H O -radicals became visible when 0 2~ ' adduct formation was prevented by superox ide dismutase (SOD) (Fig. 3B) . To understand the mechanism of H O -formation we became inter ested in the existence of a catalyst among split pro ducts formed from native AQ-glycosides. Using apolar solvents (Folch extraction) we were able to extract two major metabolites which were sepa rated by means of thin layer chromatography (Fig. 4) . The R f values of the metabolites moving with the mobile phase (CHC13, CH3 OH, C H 3 COOH; 100:2:5, on Kieselgel 60) revealed the loss of the sugar residue (Takanashi and Bachur, 1975) whereas the hydrophilic parent compound rem ained at the starting line. The m ajor product was subjected to infrared spectroscopy which revealed the loss of the car bonyl group absorption at 1710 cm -1 present in the parent compound (Fig. 5) . According to the IR-, UV/VIS-spectra, the high lipophilicity, and the chromatographic retention behavior this me tabolite was identified as a 7-deoxyadriamycinol aglycone.
A bout 25% of AQ (625 |i m ) were converted by NAD H-respiring RHM (5.25 mg/ml) into 7-deoxyadriamycinol aglycone within 30 minutes. The li pophilic m etabolite was not obtained under iden tical conditions with succinate or when liver m itochondria were used as catalysts. However, again focusing electron transfer from NADH via the exogenous N A D H dehydrogenase of RHM to A Q by the use of rotenone, stimulated the yield of 7-deoxyadriamycinol aglycone (AglAQ) signifi cantly (65% conversion). When increasing oxygen tension a complete suppression of the aglycone form ation occurred while in contrast the removal of oxygen further stimulated the yield of the lipo philic split product by a factor of 1.5.
Based on these observations we designed a m et abolic cycle in which A Q -formed from NADHrespiring m itochondria were suggested to undergo disproportionation, resulting in the existence of unstable hydroquinones which subsequently cleave off the sugar residue and form aglycone split products (Fig. 6 ). The latter decomposition step was described elsewhere (Lea et al., 1990) . Cycle B is stimulated when the competition for the common precursor AQ-was reduced (Fig. 6 ). This was possible by slowing down autoxidation rates of AQ-via reduction of oxygen tension. Due to the lipophilic character of aglycones formed we expected accumulation of these split products in the lipid phase of the inner mitochondrial mem brane. The presence of these metabolites became visible when mitochondria were supplem ented with substrates for respiration. Irrespectively whether N AD H or succinate were used AglAQ semiquinones (A glA Q -) were formed. The use of ESR technique revealed that NAD H-related AglAQ -formation most likely oc curred by free collision reaction because the ESR signal indicated the existence of non-restricted motions of this radical (Fig. 7A) . In contrast, the anisotropic shape of succinate-derived AglAQ* ESR signal indicated a physical interaction most likely with succinate dehydrogenase (Fig. 7B) . The latter appears to stabilize this AglAQ • species be cause in contrast to the freely moveable AglAQformed from a collision with the N A D H -related electron-transfer pathway the former was totally resistant to the presence of H 2 0 2. H O -radicals were found to result from an interaction of H 2 0 2 and N A D H-related AglAQ \ Fig. 7C shows the re spective spin adduct obtained from a radical reac tion of H O -with dimethyl sulfoxide (DM SO) in the presence of DMPO. Succinate could not sub- (Fig. 7D) . The disappearance of the semire duced form of AglAQ in the presence of H 2 0 2 and the form ation of HO * radicals in this reaction strongly suggested AglAQ • to catalyze the following sequence of electron cycling from the N A D H pathway to H2 0 2 (Fig. 8 ) .
The presence or absence of diethylenetriaminpentaacetic acid (DETAPAC) was not critical for this cycle excluding the catalytic involvement of contaminating traces of iron (Fig. 8 ). This observa tion is in line with earlier reports in which transi tion metals were also excluded as being involved in the transfer of single electrons from adriamycin semiquinones or ubisemiquinones to H 2 0 2 (non iron catalyzed reductive homolytic cleavage of H 2 0 2) (W interbourn, 1981; Nohl and Jordan, 1984) . Fig. 9 summarizes the toxicogenetic cycle of AQ activation which is initiated by one-electron reduc tion of AQ catalyzed through the exogenous N AD H dehydrogenase of heart mitochondria.
AQ activation through this enzyme can be con sidered as the key event in cardioselective toxicogenesis of anthracyclines. AQ-originating from this catalyst drives both aglycone formation and 0 2_ • release from autoxidizing A Q \ The latter is likely to undergo rapid dismutation and form H 2 0 2 due to the presence of cytosolic SOD. Accu m ulation of aglycones in the inner mitochondrial m em brane results from the second pathway. Agly cones interfere in the NADH-related m ito chondrial electron transfer pathway and deviate electrons to H 2 0 2 out of sequence. HO -resulting from this AglAQ --catalyzed cleavage of H 2 0 2 may be one major factor which initiates and propagates oxidative impairm ent of the mitochondrial energy production. Ischemic hearts seem to further stimu late the toxicity of AQ by two mechanisms. Due to the anaerobic glycolysis compensating for reduced m itochondrial ATP production NADH tissue levels increase which drives AQ activation. D e pression of oxygen tension favors AglAQ accumu lation in the respiratory chain, thereby stimulating reductive homolytic cleavage of H 2 0 2. We, there fore, expect a stimulation of oxidative stress in hearts with low oxygen supply. We actually have work in progress which seems to support this concept.
